Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RYZ | CRS |
|---|---|---|
| Price | $26.97 | $392.20 |
| Change today | ▲ 5.48% | ▲ 0.96% |
| Market cap | $1.40B | $19.44B |
| Return, 3 months | +6.3% | -33.5% |
| Return, year to date | +8.7% | +24.8% |
| Return, 1 year | +17.5% | +56.0% |
| P/E (TTM) | -22.1 | 37.3 |
| P/B | 1.1 | 8.7 |
| P/E percentile vs own 5y | – | 56th |
| Dividend yield | 2.78% | 0.20% |
| Revenue growth (YoY, latest qtr) | – | +12.6% |
| Net profit growth (YoY) | – | +45.4% |
| Gross margin | – | 30.6% |
| Operating margin | – | 22.5% |
| Net margin | – | 17.0% |
| Return on equity | – | 25.7% |
| Analyst target vs. price | – | +56.5% |
| Analyst buy share | – | 86% |
| RSI (14) | 63 | 31 |
| 30-day volatility | 38.3% | 28.5% |
| Max drawdown, 1 year | -34.7% | -38.0% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
